Sells shoulder replacement implant systems and related surgical planning, instruments and support to shoulder surgeons and healthcare providers.
10-K for FY2025, filed Mar 10, 2026We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently…View ↗
We developed our ecosystem with an approach to innovation that prioritizes ease of use, flexibility, predictability of outcomes and site of…View ↗
Advanced Implant Systems: Our advanced implants include a diverse range of interchangeable InSet anatomic and reverse total shoulder…View ↗
To best support our surgeon customers, we have built our product ecosystem around their unique needs. Our commercial organization is…View ↗
Surgeons and healthcare providers pay for implant products when the company receives a purchase order and confirmation that the product has been used or implanted; products are generally delivered to customers at a point in time.
10-K for FY2025, filed Mar 10, 2026
$47.3M
10-K for FY2025, filed Mar 10, 2026
$47.3M ↗
The company sells to surgeons and other stakeholders in shoulder surgical care, focusing its commercial organization on surgeons in hospitals and ambulatory surgery centers. It also reaches customers through a network of independent distributors.
10-K for FY2025, filed Mar 10, 2026
No. It lost $40.4M in FY2025.
10-K for FY2025, filed Mar 10, 2026
−$26.3MView ↗
10-K for FY2025, filed Mar 10, 2026
−$40.4MView ↗
10-K for FY2025, filed Mar 10, 2026
−$36MView ↗
10-Q for Q2 FY2026, filed Aug 6, 2026
−$10.2MView ↗
8-K, filed Aug 6, 2026
Shoulder Innovations expects net revenue for the full year 2026 to be in the range of $67 million to $69 million, representing growth of…View ↗
Competes with Arthrex, Enovis, Exectech, Johnson & Johnson, Smith & Nephew, Stryker, and Zimmer Biomet
10-K for FY2025, filed Mar 10, 2026Our industry is competitive, subject to technological change and significantly affected by new product introductions and market activities…View ↗
Loading...